Main > GASTROENTEROLOGY > Inflammatory Bowel Disease (IBD) > Treatment > RNA Blocking Drug > Co.: Sweden. I (Development)

---

Co.: Sweden. I (Development)'s subsections
Company
Exclusive Rights Owner
Status: Phase II
TradeMark
Ulcerative Colitis
UpDate: 03.01.04

Co.: Sweden. I (Development)'s products
This section has no products